MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/meg.0b013e3283488b00

Медицинская библиотека · European journal of gastroenterology & hepatology · 2011

Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.

Amer Mohie-Eldeen M, El-Sayed Samy Z, El-Kheir Wael Abou, Gabr Hala, Gomaa Ahmed A, El-Noomani Nabil, Hegazy Mohamed

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

AIM: One of the defining features of the liver is the capacity to maintain a constant size despite injury. Extrahepatic stem cells especially bone marrow-derived stem cells are thought to undertake an important role in liver repopulation. This study was carried out to evaluate the outcome of autologous bone marrow-derived hepatocytes transplantation in patients with end-stage liver cell failure due to chronic hepatitis C.

METHODS

Forty patients were included, divided into two groups. Group I: 20 patients receiving autologous bone marrow-derived mesenchymal stem cells stimulated to hepatic lineage. They were subdivided into two groups regarding the route of transplantation: intrasplenic (10) and intrahepatic (10). Group II: included 20 patients who received traditional supportive treatment. Patients were followed up using examination, laboratory investigations, abdominal ultrasonography, and evaluated by Child score, Model for End Stage Liver Disease score, fatigue scale, and performance status.

RESULTS

The results showed significant improvement in group I regarding ascites, lower limb edema, and serum albumin, over the control group. Group I also showed statistically significant improvement in Child score, Model for End Stage Liver Disease score, fatigue scale, and performance status over the controls. No difference was observed between intrahepatic and intrasplenic groups.

CONCLUSION

This study demonstrated the safety and short-term efficacy of autologous bone marrow-derived mesenchymal stem cell injection in liver cell failure. Further study is necessary to standardize the cell dose, determine the life span of the injected cells, and detect the appearance of long-term complications.

Для цитирования: Amer Mohie-Eldeen M, El-Sayed Samy Z, El-Kheir Wael Abou, Gabr Hala, Gomaa Ahmed A, El-Noomani Nabil, Hegazy Mohamed. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.. European journal of gastroenterology & hepatology. 2011. DOI: 10.1097/meg.0b013e3283488b00.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.